Detail akcie STERIS Rg online

Business Summary: STERIS Plc is a provider of products and services that support patient care with an emphasis on infection prevention. Its segments include Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. Its Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. AST segment supports medical device and pharmaceutical manufacturers through a global network of contract sterilization and laboratory testing facilities, and integrated sterilization equipment and control systems. Its Life Sciences segment provides a comprehensive offering of products and services designed to support biopharmaceutical and medical device research and manufacturing facilities, in particular those focused on aseptic manufacturing. Its portfolio includes a full suite of consumable products, equipment maintenance, specialty services, and capital equipment.
Financial Summary: BRIEF: For the nine months ended 31 December 2025, Steris PLC revenues increased 9% to $4.35B. Net income applicable to common stockholders excluding extraordinary items increased 21% to $562.2M. Revenues reflect Healthcare segment increase of 9% to $3.07B, Applied Sterilization Technologies segment increase of 11% to $849.3M, Life Sciences segment increase of 8% to $425.8M, United States segment increase of 9% to $3.19B.